Agents anti-TNFα et sarcoïdose
Tóm tắt
Từ khóa
Tài liệu tham khảo
Reimold, 2002, TNFalpha as therapeutic target: new drugs, more applications, Curr Drug Targets Inflamm Allergy, 1, 377, 10.2174/1568010023344535
Furst, 2006, Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain difference in the risk for developing granulomatous infection, Semin Arthritis Rheum, 36, 159, 10.1016/j.semarthrit.2006.02.001
Marino, 2007, Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue, PLoS Comput Biol, 3, e194, 10.1371/journal.pcbi.0030194
Siddiqui MA, Scott LJ. Infliximab: a review of its use in Crohn's disease and rheumatoid arthritis. Drugs 2005;65:2179–208.
Tubach, 2009, Risk of tuberculosis is higher with anti-tumor necrosis factor alpha monoclonal antibody than with soluble tumor factor necrosis factor receptor therapy. The three year prospective French research axe on tolerance of biotherapies registries, Arthritis Rheum, 60, 1884, 10.1002/art.24632
Bachmeyer, 2007, Granulomatous tatto reaction in a patient treated with etanercept, J Eur Acad Dermatol Venereol, 21, 550, 10.1111/j.1468-3083.2006.01949.x
Toussirot, 2008, Sarcoidosis occuring during anti-TNFalpha treatment for inflammatory rheumatic diseases: report of two cases, Clin Exp Rheumatol, 26, 471
Zissel, 2007, Sarcoidosis-immunopathogenetic concepts, Semin Respir Crit Care Med, 28, 3, 10.1055/s-2007-970329
Kikawada, 1998, Sarcoidosis induced by interferon therapy for chronic myelogenous leukaemia, Respirology, 3, 41, 10.1046/j.1440-1843.1998.d01-1.x
Denys, 2007, Steroid resistant sarcoidosis: is antagonism of TNFalpha the answer?, Clin Sci, 112, 281, 10.1042/CS20060094
Sweiss, 2007, Tumor necrosis factor inhibition in the treatment of refractory sarcoidosis: slaying the dragon?, J Rheumatol, 34, 2129
Ziegenhagen, 2003, The cytokine network in sarcoidosis and its clinical relevance, J Int Med, 253, 18, 10.1046/j.1365-2796.2003.01074.x
Sweiss, 2007, Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present and future concepts, Clin Dermatol, 25, 341, 10.1016/j.clindermatol.2007.03.012
Dai, 2005, Production of soluble tumor necrosis factor receptors and tumor necrosis factor a by alveolar macrophages in sarcodosis and extrinsic allergic alveolitis, Chest, 127, 251, 10.1378/chest.127.1.251
Baughman, 2001, Infliximab for refractory sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 18, 70
Yee, 2001, Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor alpha therapy, Ann Intern Med, 135, 27, 10.7326/0003-4819-135-1-200107030-00010
Katz, 2003, The pathogenesis and treatment of optic disc swelling in neurosarcoidosis, Arch Neurol, 60, 426, 10.1001/archneur.60.3.426
Pettersen, 2002, Refractory neurosarcoidosis responding to infliximab, Neurology, 59, 1660, 10.1212/01.WNL.0000034766.13282.33
Meyrele, 2003, The use of infliximab in cutaneous sarcoidosis, J Drugs Dermatol, 2, 413
Mallbris, 2003, Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy, J Am Acad Dermatol, 48, 290, 10.1067/mjd.2003.228
Haley, 2004, Infliximab therapy for sarcoidosis (lupus pernio), Br J Dermatol, 150, 146, 10.1111/j.1365-2133.2004.05769.x
Menon, 2004, Interferon alpha associated sarcoidosis responsive to infliximab therapy, Am J Med Sci, 328, 173, 10.1097/00000441-200409000-00008
Ulbricht, 2003, Successful tumor necrosis factor α blockade treatment in therapy resistant sarcoidosis, Arthritis Rheum, 48, 3542, 10.1002/art.11357
Roberts, 2003, Refractory sarcoidosis responding to infliximab, Chest, 124, 2028, 10.1378/chest.124.5.2028
Pritchard, 2004, Tumor necrosis factor α inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients, Ann Rheum Dis, 63, 318, 10.1136/ard.2002.004226
Agrawal, 2009, Sarcoid sacroiliitis: successful treatment with infliximab, Ann Rheum Dis, 68, 283, 10.1136/ard.2007.087155
Sweiss, 2005, Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis, Arthritis Rheum, 53, 788, 10.1002/art.21468
Saleh, 2006, Effectiveness of infliximab in treating selected patients with sarcoidosis, Respir Med, 100, 2053, 10.1016/j.rmed.2006.02.017
Toth, 2007, Dramatic MRI improvement with refractory neurosarcoidosis treated with infliximab, Acta Neurol Scand, 116, 259, 10.1111/j.1600-0404.2007.00870.x
Kumar, 2007, Neurosarcoidosis presenting as a cerebellar mass, J Gen Intern Med, 22, 1373, 10.1007/s11606-007-0272-7
Cruz, 2007, Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab, Rheumatol Int, 27, 1181, 10.1007/s00296-007-0359-9
Uthman, 2007, Cardiac sarcoidosis responding to monotherapy with infliximab, Clin Rheumatol, 26, 2001, 10.1007/s10067-007-0614-1
Salama, 2006, Optic neuropathy in refractory neurosarcoidosis treated with TNF-alpha antagonist, Can J Ophthalmol, 41, 766, 10.3129/i06-074
Hoitsma, 2006, Improvement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab, Sarcoidosis Vasc Diffuse Lung Dis, 23, 73
Ahmed, 2007, Isolated renal sarcoidosis: a rare presentation of a rare disease treated with infliximab, Clin Rheumatol, 26, 1346, 10.1007/s10067-006-0357-4
Milman, 2006, Treatment of severe sarcoidosis using TNF-alpha-inhibitor (infliximab), Ugeskr Laeger, 168, 484
Mandel, 2005, Treatment of refractory sarcoidal parotid gland swelling in a previously reported unresponsive case, J Am Dent Assoc, 136, 1282, 10.14219/jada.archive.2005.0345
Heffernan, 2005, Recalcitrant cutaneous sarcoidosis responding to infliximab, Arch Dermatol, 141, 910, 10.1001/archderm.141.7.910
Fouchier, 2004, Successful treatment with infliximab of a patient with refractory sarcoidosis, Ned Tijdschr Geneeskd, 148, 2446
Sorrentino, 2004, Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale, Inflamm Bowel Dis, 10, 438, 10.1097/00054725-200407000-00018
Sollberger, 2004, Successful treatment of steroid-refractory neurosarcoidosis with infliximab, J Neurol, 251, 760, 10.1007/s00415-004-0432-1
Carter, 2004, Refractory neurosarcoidosis: a dramatic response to infliximab, Am J Med, 117, 277, 10.1016/j.amjmed.2004.03.013
Ali, 2004, Successful treatment of sarcoidosis, Ann Intern Med, 140, W70, 10.7326/0003-4819-140-11-200406010-00028-w1
Rossman, 2006, A double blinded, randomized, placebo controlled trial of infliximab in subjects with active pulmonary sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 23, 201
Baughman, 2006, Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement, Am J Respir Crit Care Med, 174, 795, 10.1164/rccm.200603-402OC
Judson, 2008, Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomized trial, Eur Respir J, 31, 1189, 10.1183/09031936.00051907
Baughman, 2008, Inhibitors of tumor necorsis factor (TNF) in sarcoidosis: who, what, and how to use them, Sarcoidosis Vasc Lung Dis, 25, 76
Khanna, 2003, Etanercept ameliorates sarcoidosis arthritis and skin disease, J Rheumatol, 30, 1864
Hobbs, 2005, Chronic sarcoid arthritis treated with intraarticular etanercept, Arthritis Rheum, 52, 987, 10.1002/art.20936
Tuchinda, 2006, Etanercept for chronic progressive cutaneous sarcoidosis, J Drugs Dermatol, 5, 538
Le Roux, 2007, Granulomatous myositis: a clinical study of thirteen cases, Muscle Nerve, 35, 171, 10.1002/mus.20683
Utz, 2003, Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis, Chest, 124, 177, 10.1378/chest.124.1.177
Baughman, 2005, Etanercept for refractory ocular sarcoidosis: results of a double blind randomized trial, Chest, 128, 1062, 10.1378/chest.128.2.1062
Callejas-Rubio, 2006, Treatment of therapy resistant sarcoidosis with adalimumab, Clin Rheumatol, 25, 596, 10.1007/s10067-005-0037-9
Heffernan, 2006, Adalimumab for treatment of cutaneous sarcoidosis, Arch Dermatol, 142, 17, 10.1001/archderm.142.1.17
Philips, 2005, Ulcerative cutaneous sarcoidosis responding to adalimumab, J Am Acad Dermatol, 53, 917, 10.1016/j.jaad.2005.02.023
Marnane, 2009, Steroid unresponsive neurosarcoidosis successfully treated with adalimumab, J Neurol, 256, 139, 10.1007/s00415-009-0077-1
Hashkes, 2003, Sarcoid related uveitis occurring during etanercept therapy, Clin Exp Rheumatol, 21, 645
Gonzalez-Lopez, 2006, Development of sarcoidosis during etanercept therapy, Arthritis Rheum, 55, 817, 10.1002/art.22238
Phillips, 2005, Granulomatous lung disease occurring during etanercept treatment, Arthritis Rheum, 53, 618, 10.1002/art.21336
Almodovar, 2007, Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab, Clin Exp Rheumatol, 25, 99
Verschueren, 2007, Development of sarcoidosis in etanercept treated rheumatoid arthritis patients, Clin Rheumatol, 26, 1969, 10.1007/s10067-007-0594-1
O'Shea, 2006, Pulmonary sarcoidosis developing during infliximab therapy, Arthritis Rheum, 55, 978, 10.1002/art.22351
Vavricka, 2003, Pulmonary granulomas after tumor necrosis factor alpha antagonist therapy, Thorax, 58, 278, 10.1136/thorax.58.3.278
Peno-Green, 2002, Lung injury linked to etanercept therapy, Chest, 122, 1858, 10.1378/chest.122.5.1858
Sturfelt, 2007, Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab, J Rheumatol, 34, 2313
Farah, 2007, Pulmonary sarcoidosis associated with etanercept therapy, Pharmacotherapy, 27, 1446, 10.1592/phco.27.10.1446
Dubosc, 2008, Cutaneous granulomas during infliximab therapy for spondyloarthropathy, J Rheumatol, 35, 1222
Louie, 2008, Relapse of sarcoidosis upon treatment with etanercept, Ann Rheum Dis, 67, 896, 10.1136/ard.2007.078840
Massara, 2010, Sarcoidosis appearing during anti-tumor necrosis factor a therapy: a new class effect paradoxical phenomenon. Two case reports and literature review, Semin Arthritis Rheum, 39, 313, 10.1016/j.semarthrit.2008.11.003
Kudrin, 2007, Sarcoid-like granulomatous disease following etanercept treatment for rheumatoid arthritis, J Rheumatol, 34, 648
Ishiguro, 2008, Development of sarcoidosis during etanercept therapy, Intern Med, 47, 1021, 10.2169/internalmedicine.47.0602
Daien, 2009, Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases, Rheumatology (Oxford), 48, 883, 10.1093/rheumatology/kep046
Song, 2008, New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept, J Rheumatol, 35, 532
Toussirot, 2009, Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis under TNFalpha blocking agent: a series of 11 cases, J Rheumatol, 36, 2421, 10.3899/jrheum.090030
Menard, 1995, Association of histologically proven rheumatoid arthritis with pulmonary sarcoidosis, Eur Respir J, 8, 72, 10.1183/09031936.95.08030472
Ritchlin, 2006, A medical conundrum: onset of psoriasis in patients receiving anti tumor necrosis factor agents, Ann Rheum Dis, 65, 1541, 10.1136/ard.2006.059261